Bacteria belong in the colon. When they overgrow in the small intestine, they start fermenting carbohydrates before the body can absorb them. Gas accumulates. Bloating follows. Over time, genuine malnutrition sets in because nutrients are being consumed by bacteria before they reach the bloodstream. SIBO gets missed routinely not because it’s rare, but because it looks like IBS on the outside and nobody orders the test that would catch it. And treating IBS when SIBO is the actual driver produces results that look exactly like IBS treatment failure.
According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “SIBO gets missed because bloating and altered bowel habits get labelled IBS without a breath test. When IBS treatment fails repeatedly, SIBO should be on the list a hydrogen breath test tells you something a colonoscopy can’t.”
Bloating and loose stools that haven’t responded to standard IBS treatment?
What Tests Are Used to Diagnose SIBO?
Breath tests are non-invasive and practical. But each one has limits, and the gas type changes what the result means.
- Glucose breath test: Glucose is absorbed in the upper small bowel bacteria fermenting it before that happens produces a hydrogen or methane rise within 90 minutes. Reliable for proximal SIBO specifically.
- Lactulose breath test: Lactulose travels the full small bowel length unabsorbed. A double-peak pattern suggests SIBO, but interpretation is genuinely harder than glucose testing and false positives are more common.
- Jejunal aspirate: Small bowel fluid sampled directly via endoscopy and cultured. Over 10³ colony-forming units per mL confirms overgrowth the technical gold standard, used when breath tests come back equivocal.
- Gas type identification: Hydrogen links to diarrhoea-predominant symptoms. Methane, now called intestinal methanogen overgrowth, drives constipation. Hydrogen sulphide needs a separate panel. An experienced endoscopist decides which test matches the symptom pattern before ordering anything.
IBS treatment that keeps failing despite dietary compliance is the clinical signal — SIBO drives a meaningful chunk of IBS-D cases and doesn’t respond to gut-directed IBS therapy at all.
What Conditions Create the Environment for SIBO?
SIBO doesn’t appear from nowhere. Finding what opened the door to it changes whether it comes back.
- Motility disorders: Slow small bowel transit lets bacteria pool where they shouldn’t. Diabetic gastroparesis, scleroderma, and post-surgical dysmotility are the usual culprits treat the motility problem or SIBO keeps returning.
- Low stomach acid: Long-term PPI use, autoimmune gastritis, prior gastric surgery all reduce the acid barrier that limits bacterial passage into the small bowel. Worth reviewing medication history before antibiotic treatment starts.
- Structural problems: Strictures, adhesions, small bowel diverticula, and stagnant loops let bacteria accumulate. Colonoscopy and small bowel imaging map structural causes that no breath test can show.
- Post-infectious trigger: A gastroenteritis episode damages the interstitial cells of Cajal that drive the migrating motor complex the gut’s housekeeping mechanism. Without it, bacteria that should be cleared downstream aren’t.
People who alternate between constipation and diarrhoea without a clear trigger and haven’t responded to standard management need a predisposing cause worked up alongside the breath test the cause, not just the bacteria.
How Is SIBO Treated Once the Diagnosis Is Confirmed?
Treatment follows the gas type. Not symptoms. Not a default antibiotic protocol.
- Rifaximin: Non-absorbed antibiotic, stays in the gut lumen. First-line for hydrogen-dominant SIBO. Two-week course response confirmed on a repeat breath test, not assumed from how the patient feels.
- Rifaximin plus neomycin: Methane-dominant IMO needs both agents. Neomycin targets methanogens that rifaximin alone doesn’t clear the combination outperforms monotherapy in constipation-predominant cases.
- Elemental diet: Liquid formula absorbed proximally, nothing left distally to ferment. Reduces bacterial load effectively used when antibiotics have failed or aren’t tolerated. Two weeks is a significant commitment.
- Fixing the underlying cause: Stopping unnecessary PPIs, adding prokinetics post-treatment, correcting structural issues where possible. Skip this step and SIBO recurrence within three to six months isn’t unusual.
Understanding how SIBO overlaps with IBD and IBS diagnostically matters: all three produce bloating and altered bowel habits, and getting the diagnosis wrong means the right drug is treating the wrong condition.
Key Takeaways
- SIBO looks like IBS on symptoms only a breath test separates them, not a clinical impression
- Which gas the test identifies determines which antibiotic gets used; guessing the drug without knowing the gas type is the main reason SIBO treatment fails
- Jejunal aspirate culture is the gold standard but reserved for cases where breath tests don’t give a clear answer
- Finding the predisposing cause motility disorder, low acid, structural issue is what stops SIBO from coming back
- Repeat breath test confirms treatment response; feeling better doesn’t
- Recurrence is the default outcome when the underlying driver isn’t corrected alongside antibiotics
Frequently Asked Questions
It’s the practical first-line test; jejunal aspirate culture is more definitive but reserved for equivocal results.
Hydrogen produces diarrhoea and responds to rifaximin; methane causes constipation and needs an added antibiotic.
Yes, recurrence is common when the predisposing cause isn’t addressed alongside the antibiotic course.
Rifaximin runs for two weeks; response should be confirmed with a repeat breath test, not assumed from symptoms.
Disclaimer: The information shared in this content is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Please consult a qualified gastroenterologist for guidance specific to your condition.
